167 related articles for article (PubMed ID: 37865508)
1. Childhood Myelodysplastic Syndrome.
Chisholm KM; Bohling SD
Clin Lab Med; 2023 Dec; 43(4):639-655. PubMed ID: 37865508
[TBL] [Abstract][Full Text] [Related]
2. The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia.
Rudelius M; Weinberg OK; Niemeyer CM; Shimamura A; Calvo KR
Virchows Arch; 2023 Jan; 482(1):113-130. PubMed ID: 36445482
[TBL] [Abstract][Full Text] [Related]
3. Pediatric Myelodysplastic Syndromes.
Patel SS
Clin Lab Med; 2021 Sep; 41(3):517-528. PubMed ID: 34304779
[TBL] [Abstract][Full Text] [Related]
4. Childhood myelodysplastic syndrome.
Chatterjee T; Choudhry VP
Indian J Pediatr; 2013 Sep; 80(9):764-71. PubMed ID: 23912822
[TBL] [Abstract][Full Text] [Related]
5. Differences in the bone marrow histology between childhood myelodysplastic syndrome with multilineage dysplasia and refractory cytopenia of childhood without multilineage dysplasia.
Iwafuchi H; Ito M
Histopathology; 2019 Jan; 74(2):239-247. PubMed ID: 30062702
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults.
Marchesi RF; Velloso EDRP; Garanito MP; Leal AM; Siqueira SAC; Azevedo Neto RS; Rocha V; Zerbini MCN
Ann Diagn Pathol; 2020 Apr; 45():151459. PubMed ID: 32000075
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and treatment of childhood myelodysplastic syndrome].
Hasegawa D
Rinsho Ketsueki; 2021; 62(4):229-238. PubMed ID: 33967145
[TBL] [Abstract][Full Text] [Related]
8. Pediatric myelodysplastic syndromes: they do exist!
Glaubach T; Robinson LJ; Corey SJ
J Pediatr Hematol Oncol; 2014 Jan; 36(1):1-7. PubMed ID: 24345881
[TBL] [Abstract][Full Text] [Related]
9. Challenges in Diagnosing Myelodysplastic Syndromes in the Era of Genetic Testing: Proceedings of the 13th Workshop of the European Bone Marrow Working Group.
Hebeda KM; Tzankov A; Boudova L; Saft L; Hasserjian RP; de Boer M; Fend F; Orazi A; Leguit R
Pathobiology; 2019; 86(1):62-75. PubMed ID: 29982244
[TBL] [Abstract][Full Text] [Related]
10. Myelodysplastic syndromes in children.
Galaverna F; Ruggeri A; Locatelli F
Curr Opin Oncol; 2018 Nov; 30(6):402-408. PubMed ID: 30222640
[TBL] [Abstract][Full Text] [Related]
11. Myelodysplastic neoplasms evolving from inherited bone marrow failure syndromes / germline predisposition syndromes: Back under the microscope.
Elghetany MT; Patnaik MM; Khoury JD
Leuk Res; 2024 Feb; 137():107441. PubMed ID: 38301422
[TBL] [Abstract][Full Text] [Related]
12. Lessons From Pediatric MDS: Approaches to Germline Predisposition to Hematologic Malignancies.
Avagyan S; Shimamura A
Front Oncol; 2022; 12():813149. PubMed ID: 35356204
[TBL] [Abstract][Full Text] [Related]
13. The Times, They Are A-Changing: The Impact of Next-Generation Sequencing on Diagnosis, Classification, and Prognostication of Myeloid Malignancies With Focus on Myelodysplastic Syndrome, AML, and Germline Predisposition.
Gurbuxani S; Hochman MJ; DeZern AE; Shimamura A
Am Soc Clin Oncol Educ Book; 2023 Jun; 43():e390026. PubMed ID: 37307513
[TBL] [Abstract][Full Text] [Related]
14. Spectrum of Myelodysplastic Syndrome in Patients Evaluated for Cytopenia(s). A Report from a Reference Centre in Saudi Arabia.
AlMozain N; Mashi A; Alneami Q; Al-Omran A; Bakshi N; Owaidah T; Khalil S; Khogeer H; Hashmi S; Al-Sweedan S; Morris T; AlNounou R
Hematol Oncol Stem Cell Ther; 2022 Jun; 15(2):39-44. PubMed ID: 33227261
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood.
Aalbers AM; van den Heuvel-Eibrink MM; Baumann I; Dworzak M; Hasle H; Locatelli F; De Moerloose B; Schmugge M; Mejstrikova E; Nováková M; Zecca M; Zwaan CM; Te Marvelde JG; Langerak AW; van Dongen JJ; Pieters R; Niemeyer CM; van der Velden VH
Haematologica; 2015 Mar; 100(3):315-23. PubMed ID: 25425683
[TBL] [Abstract][Full Text] [Related]
16. MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations.
McReynolds LJ; Yang Y; Yuen Wong H; Tang J; Zhang Y; Mulé MP; Daub J; Palmer C; Foruraghi L; Liu Q; Zhu J; Wang W; West RR; Yohe ME; Hsu AP; Hickstein DD; Townsley DM; Holland SM; Calvo KR; Hourigan CS
Leuk Res; 2019 Jan; 76():70-75. PubMed ID: 30578959
[TBL] [Abstract][Full Text] [Related]
17. The utility of a myeloid mutation panel for the diagnosis of myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasm.
Ibrar W; Zhang W; Cox JL; Cushman-Vokoun A; Fu K; Greiner TC; Yuan J
Int J Lab Hematol; 2021 Dec; 43(6):1501-1509. PubMed ID: 34270867
[TBL] [Abstract][Full Text] [Related]
18. Genetic Predisposition to Myelodysplastic Syndrome in Clinical Practice.
Schratz KE; DeZern AE
Hematol Oncol Clin North Am; 2020 Apr; 34(2):333-356. PubMed ID: 32089214
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic work-up of hematological malignancies with underlying germline predisposition disorders (GPD).
Kanagal-Shamanna R; Schafernak KT; Calvo KR
Semin Diagn Pathol; 2023 Nov; 40(6):443-456. PubMed ID: 37977953
[TBL] [Abstract][Full Text] [Related]
20. Pediatric Hematopathology in the Era of Advanced Molecular Diagnostics: What We Know and How We Can Apply the Updated Classifications.
Liu YC; Geyer JT
Pathobiology; 2024; 91(1):30-44. PubMed ID: 37311434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
